Hologic of Bedford, Massachusetts has released a new version of its popular NovaSure endometrial ablation system, designed for office or outpatient treatment of excessive menstrual bleeding, or menorrhagia.
The NovaSure endometrial ablation system, manufactured and marketed by Hologic, Inc., is a next-generation, minimally invasive treatment for excessive menstrual bleeding, or menorrhagia. The NovaSure system works by applying a 90-second, precisely-controlled dose of radio-frequency energy to remove the lining of the uterus. Unlike other endometrial ablation treatments, the NovaSure procedure is customized to each patient and requires no hormonal pre-treatment, which is often associated with side-effects and treatment delays. It can be performed in an outpatient setting or doctor’s office at any time during the menstrual cycle, increasing flexibility for both the patient and physician. The NovaSure procedure provides a safe and effective alternative to hysterectomy and oral contraceptive therapy for women suffering from excessive menstrual bleeding.
Press release: Hologic Unveils Next Generation NovaSure Endometrial Ablation System…
Product page: NovaSure Procedure…
Flashback: NovaSure® Endometrial Ablation System…